Product Images Ceftriaxone Sodium

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 3 images provide visual information about the product associated with Ceftriaxone Sodium NDC 60505-6150 by Apotex Corp., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Ceftriaxone 10 g/vial Carton Label - carton label 10g

Ceftriaxone 10 g/vial Carton Label - carton label 10g

Ceftriaxone 10 g/vial Label - container label 10g

Ceftriaxone 10 g/vial Label - container label 10g

This is a description of Apotex Corp's Ceftriaxone for Injection, USP which comes in a vial containing powder equivalent to 10g of Ceftiaxone for intravenous use only. The package is not intended to be dispensed as a unit. Each 1ml of solution contains 100 mg equivalent of Ceftriaxone. A Pharmacy Bulk Package is intended for use in a Pharmacy Admixture Service. After withdrawal, the contents should be discarded no later than 4 hours after initial closure puncture if prompt fluid transfer standards cannot be followed. Further dilution is required before use. It is manufactured in China by Qilu Pharmaceutical Co., Ltd. for Apotex Corp., Westin, FL 33326. Storage prior to reconstitution should be at 20° o 25°C (68° to 77°F) and protected from light. Storage after reconstitution is specified in the package insert. The recommended usual dosage and prescribing information should be read before use. The code number for this product is 340400020048 and its GTIN is 0360505615053.*

Ceftriaxone Chemical Structure - structure

Ceftriaxone Chemical Structure - structure

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.